[JANX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
08-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -1.64%
YoY- -4.42%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 439 8,897 1,252 2,461 2,517 1,057 2,048 -64.08%
PBT -28,059 -5,959 -14,760 -11,758 -11,568 -17,508 -17,459 37.08%
Tax 0 0 489 953 -500 349 -453 -
NP -28,059 -5,959 -14,760 -11,758 -11,568 -17,508 -17,459 37.08%
Tax Rate - - - - - - - -
Total Cost 28,498 14,856 16,012 14,219 14,085 18,565 19,507 28.66%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -6,391.57 -66.98 -1,178.91 -477.77 -459.59 -1,656.39 -852.49 281.66%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.51 -0.11 -0.30 -0.25 -0.25 -0.42 -0.42 13.77%
EPS Diluted -0.51 -0.11 -0.30 -0.25 -0.25 -0.42 -0.42 13.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.